Go Pro

Astera Labs (NASDAQ:ALAB) Trading Down 1.9% - What's Next?

Astera Labs logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Astera Labs shares fell 1.9% to $284.97 in mid-day trading, with volume 45% below the average session level. The stock has a $49.44 billion market capitalization and trades at a high price-to-earnings ratio of 141.07.
  • Analyst sentiment remains positive overall, with a consensus “Moderate Buy” rating and a $333 target price. Recent targets range from $325 at Barclays to $450 at Jefferies, while UBS maintained a neutral rating with a $425 target.
  • The company exceeded quarterly expectations, reporting $0.80 EPS versus the $0.69 consensus and revenue of $392.4 million, up 104.5% year over year. Executives also sold shares to cover tax obligations tied to equity awards, while institutional investors own 60.47% of the stock.
  • MarketBeat previews top five stocks to own in September.

Shares of Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) were down 1.9% during mid-day trading on Friday . The company traded as low as $277.30 and last traded at $284.97. 2,999,423 shares changed hands during trading, a decline of 45% from the average session volume of 5,451,113 shares. The stock had previously closed at $290.52.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the company. Zacks Research raised Astera Labs from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, August 11th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Astera Labs in a research report on Tuesday. UBS Group restated a "neutral" rating and issued a $425.00 price objective on shares of Astera Labs in a report on Wednesday, August 5th. Barclays increased their price target on Astera Labs from $200.00 to $325.00 and gave the company an "equal weight" rating in a research report on Monday, July 20th. Finally, Jefferies Financial Group raised their target price on shares of Astera Labs from $270.00 to $450.00 and gave the company a "buy" rating in a research note on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $333.00.

Check Out Our Latest Report on ALAB

Astera Labs Price Performance

The company has a market cap of $49.44 billion, a price-to-earnings ratio of 141.07 and a beta of 3.84. The firm has a 50-day moving average price of $354.34 and a 200 day moving average price of $244.64.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million during the quarter, compared to analysts' expectations of $360.85 million. During the same quarter in the previous year, the business posted $0.44 earnings per share. Astera Labs's quarterly revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insider Activity at Astera Labs

In other news, COO Sanjay Gajendra sold 90,630 shares of the stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the transaction, the chief operating officer owned 1,119,038 shares of the company's stock, valued at approximately $380,864,583.30. This represents a 7.49% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Jitendra Mohan sold 90,630 shares of the firm's stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief executive officer owned 1,266,665 shares in the company, valued at $431,109,432.75. This represents a 6.68% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 419,244 shares of company stock worth $163,135,169 in the last 90 days. Corporate insiders own 10.40% of the company's stock.

Institutional Investors Weigh In On Astera Labs

Several hedge funds have recently added to or reduced their stakes in the business. Royal Bank of Canada grew its stake in shares of Astera Labs by 167.3% in the first quarter. Royal Bank of Canada now owns 152,453 shares of the company's stock worth $9,097,000 after purchasing an additional 95,409 shares during the last quarter. AQR Capital Management LLC boosted its stake in shares of Astera Labs by 213.4% in the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company's stock valued at $680,000 after purchasing an additional 7,756 shares during the last quarter. Empowered Funds LLC lifted its holdings in Astera Labs by 917.3% in the first quarter. Empowered Funds LLC now owns 4,639 shares of the company's stock valued at $277,000 after buying an additional 4,183 shares during the period. First Trust Advisors LP grew its holdings in Astera Labs by 102.0% during the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company's stock worth $10,196,000 after acquiring an additional 56,952 shares during the period. Finally, Brown Advisory Inc. boosted its position in shares of Astera Labs by 54.9% during the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company's stock valued at $505,000 after purchasing an additional 1,977 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines